PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15 | – | 2,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 15,594,877 | $1,115,813,000 | 9.76% |
| Baker Brothers Advisors | 10,118,636 | $723,988,000 | 2.73% |
| Rock Springs Capital Management LP | 360,363 | $25,784,000 | 0.55% |
| HHLR ADVISORS, LTD. | 750,000 | $53,663,000 | 0.43% |
| Old Well Partners, LLC | 3,450 | $247,000 | 0.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 111,065 | $7,947,000 | 0.11% |
| PERSONAL CFO SOLUTIONS, LLC | 4,500 | $322,000 | 0.08% |
| ARS Investment Partners, LLC | 7,400 | $529,000 | 0.06% |
| CAAS CAPITAL MANAGEMENT LP | 50,000 | $3,578,000 | 0.03% |
| FMR LLC | 4,209,963 | $296,295,000 | 0.03% |